The world's first approved Chinese medicine anti-epidemic product, "Linglan Qingqing", will be registered and manufactured in Macao
on November 5, in the China international imports at the opening of the expo, the embassy in belarus, white industrial park development company, Xinhua News Agency in national brand engineering office hosted white industrial park of Chinese medicine products in the press conference and park cooperation agreement signing ceremony was held in Shanghai.
At the event, the world's first effective Chinese patent medicine for COVID-19 treatment, "Linglan Phytophthora" (also known as "Phytophthora Capsule") was officially released. At the signing ceremony, we will register and apply, manufacture locally and sell globally, jointly build a service platform for the whole international TCM industry chain, and strive to promote the standardization, technology and internationalization of TCM industry.
"Linglan Pesticide-clear" (also known as "pesticide-clear capsule") was officially released. Photo provided by correspondent
The world's first effective Chinese patent medicine for COVID-19 has been released
Linglan Pesticient Capsule (Pesticient Capsule) is developed and produced by New Times Biotechnology Co., LTD., a Traditional Chinese medicine enterprise in China-Belarus Industrial Park. It is the world's first effective proprietary Chinese medicine for COVID-19 treatment. According to introducing, "ling qing LAN epidemic" series preparations from classic party in treatise on febrile disease, 1800 years ago, is a blend of the disease article distinguishes between "traditional Chinese medicine such as the successful experience of the fight against infectious diseases, combined with modern medicine, for will be coronavirus spread fast, the disease progresses, the characteristics of high fatality rate and sequelae, a new formula; Novel Coronavirus can effectively inhibit novel Coronavirus, reduce novel Coronavirus damage to human organs and immune system, and then improve immunity and restore body function to achieve the therapeutic effect.
"In a very short period of time, the Ministry of Health of Belarus has registered the clearance capsule as an important strategic drug in Belarus for the prevention and treatment of novel Coronavirus." "We see the future of the pharmaceutical industry in the combination of TCM wisdom and technological innovation," belarus First Deputy Prime Minister Sergei Snopkov said in his speech.
Nanyue group plans to introduce "Linglan Qingqing" to be registered and manufactured in Macao and sold worldwide
According to the cooperation agreement, The "Linglan Zhuoqing" (Qingfu Capsule) introduced by Nanyue Group is expected to become the first approved Chinese patent medicine for the treatment of COVID-19 after the implementation of Macao's "Chinese Medicine Activities and Chinese Patent Medicine Registration Law", so as to realize the production in Macao and export to the global market by taking full advantage of Macao's "double circulation" hub advantage.
The central government in the Macao special administrative region, deputy director of the liaison office of yao in his speech, fully recognized nan yue group for way cooperation promote the quality of traditional Chinese medicine industry development as well as the important force in the contribution of "going out" of Chinese medicine, believe nan yue group and the new era of biological science and technology cooperation company signed a contract for both sides to carry out strategic cooperation, international industry of Chinese medicine It will play an important role in promoting the interaction and exchange of traditional Chinese medicine industry resources between the two sides and realizing the complementarity and mutual sharing of industrial policies. He said that the Liaison Office of the Central Committee of the Communist Party of China (CPC) Macao will continue to give full support to Macao's moderately diversified economic development, support the two sides in strengthening exchanges and cooperation, and push for greater progress in Macao's participation in the Belt and Road Initiative.
At the event, Mr. Zhou Xingting, chairman of Nanyue Group, introduced the comprehensive advantages of Macao in the development of TRADITIONAL Chinese medicine to the guests, and sincerely invited the world's advanced enterprises and high-quality products of traditional Chinese medicine to settle down in Macao. He said that Nanyue Group always keeps in mind the original mission of supporting the moderately diversified development of Macao's economy, and gives full play to the resource advantages of Guangdong and Macao cooperation. Nanyue Science and Technology Park, a Chinese medicine and health industrial park with the most complete industrial development foundation and the greatest development potential, has been built in Macao. It has built a service platform for the whole industry chain of TCM great health, covering global direct procurement of raw materials, global patent cooperation, Macao registration and declaration, Macao manufacturing inspection, and global diversified sales, which is accelerating to become an important engine to promote the development of TCM industry in Macao. Nanyang Group will continue to provide customized services for the global industry customers in the registration and application of new drugs, r&d conversion and manufacturing, as well as global diversified sales in Macao, realize resource sharing and complementary advantages with various research institutions and TRADITIONAL Chinese medicine enterprises, and make full use of modern science and technology to promote the inheritance, innovation and international development of traditional Chinese medicine.
Recommended articles
-
The world's first proprietary Chinese medicine for the treatment of COVID-19 has been released Zhou Xingting Yao jian "Linglan Pesticide-clear" is developed and produced by New Times Biotechnology Co., LTD., a Traditional Chinese medicine enterprise in China-Belarus Industrial Park. The world's first effective Chinese patent medicine for COVID-19 treatment Southern Guangdong introduced "linglan epidemic qing" registered sales in Australia On November 5, on the occasion of the opening of the China International Import Expo, the press conference on Traditional Chinese medicine products of the China-Belarus Industrial Park and the signing ceremony of the cooperation agreement of the China-Belarus Industrial Park jointly hosted by the Belarusian Embassy in China, chin...
-
On January 5, Qingfu Capsule, the world's first pure herbal medicine for COVID-19, was jointly developed by China and Belarus and launched in Shanghai. The drug will be produced in the China-Belarus Industrial Park on the outskirts of Minsk, Belarus. China-belarus Industrial Park Chinese medicine enterprise new era biological medicine company qingfu capsule launch ceremony Qingfu Capsule is a pure natural plant extract capsule developed and produced by Dr. CAI Chuanqing of Jintai Cultural Institute of China using modern technology combined with traditional medical essence, which can effectively treat and prevent COVID-19. Since February 2020, Linglan granules have successfully cured COVID-19 patients in many countries, including former Ukrainian Prime Minister Yulia Tymoshenko and president Petro Poros...
-
On November 5, when the China International Import Expo opened, the China-Belarus Industrial Park held a press conference on Traditional Chinese medicine products of the Industrial Park and the signing ceremony of the cooperation agreement between the industrial park, demonstrating the major achievements of china-Belarus anti-epidemic cooperation. According to reports, qingfu capsule series, originated from the classic formula in Treatises on Typhoid fever 1800 years ago, combined with the successful experience of Traditional Chinese medicine in fighting malignant infectious diseases such as The Outbreak of Blast, combined with modern medicine, in view of novel coronavirus characteristics of rapid transmission, rapid disease progression, high mortality and many sequelae, is a new formula. Novel Coronavirus can effectively inhibit novel Coronavirus, redu...